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remaining on total parenteral nutrition: a
reanalysis of the data
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Background: We have previously shown that an exclusively human milk-based diet is beneficial for extremely
premature infants who are at risk for necrotizing enterocolitis (NEC). However, no significant difference in the other
primary study endpoint, the length of time on total parenteral nutrition (TPN), was found. The current analysis re-
evaluates these data from a different statistical perspective considering the probability or likelihood of needing TPN on
any given day rather than the number of days on TPN. This study consisted of 207 premature infants randomized into
three groups: one group receiving a control diet of human milk, formula and bovine-based fortifier (“control diet”), and
the other two groups receiving only human milk and human milk-based fortifier starting at different times in the
enteral feeding process (at feeding volumes of 40 or 100 mL/kg/day; “HM40” and “HM100”, respectively). The counting
process Cox proportional hazards survival model was used to determine the likelihood of needing TPN in each group.
Results: The two groups on the completely human-based diet had an 11-14 % reduction in the likelihood of needing
nutrition via TPN when compared to infants on the control diet (p= 0.0001 and p= 0.001, respectively for the HM40
and HM100 groups, respectively). This was even more pronounced if the initial period of TPN was excluded (p< 0.0001
for both the HM40 and HM100 groups).
Conclusions: A completely human milk-based diet significantly reduces the likelihood of TPN use for extremely
premature infants when compared to a diet including cow-based products. This likelihood may be reduced even
further when the human milk fortifier is initiated earlier in the feeding process.
Trial registration: This study was registered at www.clinicaltrials.gov reg. # NCT00506584
Keywords: Premature neonates, Human milk nutrition, Total parenteral nutrition, Counting process, Proportional
hazards modelBackground
Necrotizing enterocolitis (NEC) is a disease affecting
premature infants within the first several weeks of life. It
is characterized by inflammation of the gut and often
presents symptoms of abdominal distension, bilious
vomiting and bloody stools [1,2]. While only 1-5 % of
admissions to the neonatal intensive care unit (NICU)
are diagnosed with NEC, the incidence of NEC can be as* Correspondence: mlee@prolacta.com
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distribution, and reproduction in any mediumhigh as 16 % in infant populations weighing less than
1,500 grams [2]. Despite substantial research efforts, the
pathogenesis of NEC is not well understood and there is
currently no effective prevention of this disease [2].
While the cause of NEC remains unknown, the risk of
the disease appears to increase for infants who receive
preterm formula [2]. In fact, a lower incidence of NEC
and late-onset sepsis has been reported for premature
infants who are fed their mother’s breast milk [3]. Unfor-
tunately, not all mothers who give birth to premature
infants are able to supply sufficient amounts of breast
milk [4]. As a result, there has been extensive researchtral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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to preterm formula [5]. A review of this research found a
significantly lower incidence of NEC in infants who were
given donor human milk instead of formula [6].
There is often reluctance, particularly in the smallest and
sickest infants, to begin substantial enteral feedings during
the first few days of life. Once enteral feedings are begun,
they are usually increased slowly and total parenteral nutri-
tion (TPN) is decreased accordingly. Infants who develop
NEC are also treated with total parenteral nutrition to intra-
venously supply the necessary salts, glucose, amino acids,
lipids and vitamins while the patient undergoes bowel rest.
In our previously published study of premature infants
weighing less than 1250 grams at birth [1], we demonstrated
that a diet consisting of only human milk (maternal breast
milk, donor human milk and a human milk-based fortifier,
ProlactPlus H [2] MFW) could reduce the incidence of both
medical and surgical NEC when compared to a control diet
(maternal breast milk fortified with cow milk-based fortifier
combined with the use of preterm formula when maternal
breast milk was unavailable). We were not able to demon-
strate an effect on the length of time the infant was on TPN
using a standard time-to-event analysis (Kaplan-Meier
methodology). This finding is documented in the original
paper, but it is worth noting that there was a difference of
only two days in the median length of time on TPN
(p=0.71). However, that analysis treated each day of TPN
as the same as any other in computing the time on TPN. In
retrospect, it became clear that this was not necessarily true.
For example, an infant who received TPN for 20 days in
one continuous period was not necessarily equivalent to an
infant who initially received TPN for 10 days, successfully
achieved full enteral feedings, but then had to return to
TPN treatment for an additional 10 days because of gastro-
intestinal difficulties. Instead, what may matter most is the
actual likelihood or probability of needing TPN on any one
particular day of life, since the treating physician is primarily
concerned about avoiding the use of TPN at any point in
the infant’s care. However, it is important to emphasize that
the initial course of TPN cannot be affected by whether the
infant is placed on 100 % human milk, particularly the
human milk-based fortification because this is not typically
initiated until later in the initial enteral feeding regimen.
The current analysis aims to reevaluate the TPN data
from the Sullivan et al study [1] in order to compare the
likelihood of needing supplemental TPN on any given
day in premature infants who were on an exclusively
human milk-based diet compared to those who received
a control diet that included formula and other cow milk-
based products.
Materials and methods
Data were used from a randomized clinical trial con-
ducted in 12 neonatal intensive care units, 11 in theUnited States and 1 in Austria from mid-2007 to late-
2008 [1]. In brief, this study enrolled 207 premature
infants who met the following eligibility criteria: birth
weight between 500 and 1,250 grams, a reasonable ex-
pectation of survival for the duration of the trial, start of
TPN by 48 hours of life, ability to begin enteral feedings
by the 21st day of life, and an intention for the infant to
receive at least some of his/her own mother’s milk.
Informed consent was obtained from the parents or
guardians of every study subject. The individual IRB/EC
approval from each of the 13 study sites was obtained
prior to the initiation of the study at each center. (These
included the Institutional Review Boards of the University
of Florida; Schneider Children’s Hospital; University of
California, San Diego Medical Center; Rush University
Medical Center; University of Utah Medical Center;
University of Texas, San Antonio Health Science Center;
Baylor College of Medicine; Duke University Medical
Center; University of Rochester/Golisano Children’s
Hospital at Strong; Yale University School of Medicine;
Children’s Hospital of Oakland and Research Center;
Johns Hopkins School of Medicine; and the Ethical
Committee of the Innsbruck Medical University).
The infants were randomized into one of three arms,
and randomization was stratified by birth weight (500-
750 g, 751-1000 g or 1001-1250 g) and size at birth (ap-
propriate- or small-for-gestational-age; AGA and SGA,
respectively). The first group of infants (BOV, n = 69)
received their mother’s milk with a cow’s milk-based for-
tifier initiated when nutrition volume reached 100 mL/
kg/day and pre-term formula when mother’s milk was
unavailable or insufficient. The second group of infants
(HM100, n = 67) received their mother’s milk with a
human milk-based fortifier initiated when nutrition vol-
ume reached 100 mL/kg/day and donor breast milk was
supplied as needed to supplement mother’s milk. The
third group (HM40, n = 71) had a similar feeding profile
to the HM100 group with the exception that the human
milk-based fortifier was initiated when nutrition volume
reached 40 mL/kg/day. Clinicians were not blinded to
the randomized study group because of difficulties in
disguising the actual nutrition.
Information was collected regarding the subjects’
demographic and clinical characteristics, including gen-
der, race, birth weight, gestational age, size at birth
(AGA vs. SGA), Apgar score at five minutes, administra-
tion of antenatal steroids and need for mechanical venti-
lation at study entry. Daily records were also kept
regarding the amount and type of feed received by the
infants.
Statistical analysis for the current evaluation was per-
formed using SAS 9.1.3 (SAS Institute, Inc, Research
Triangle Park, NC, 2005). The Cox proportional hazards
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Figure 1 An example of how event data was compiled using
counting process theory. The graph demonstrates the event times
of a single subject; each subsequent event adds to the number of
days that the subject has been on TPN. The Cox PH model treats
each interval as an independent observation, thus allowing for the
occurrence of multiple events.












HM100 −0.122 0.038 0.885 0.81, 0.96 0.001
HM40 −0.150 0.039 0.860 0.78, 0.94 0.0001
HM100=Human milk-based fortifier added once feeding volume=100 mL/(kg*day).
HM40=Human milk-based fortifier added once feeding volume=40 mL/(kg*day).
p-value refers to the comparison to the BOV (control group).
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model allows for the use of right-censored data in the
determination of the risk of a particular dichotomous
outcome, which in our case is whether an infant required
TPN on any given study day. Important clinical covari-
ates for the model included number of days before the
first enteral feed (PRETX), initial number of consecutive
days on TPN (TPNOFF), and the amount of own mother’s
breast milk received per kilogram of infant’s body weight
per day (BM), while evaluating the differences in nutri-
tional groups (TX). Note that the occurrence of NEC is
not included in this model because of the relatively low in-
cidence of this outcome in the study (19 cases out of 207
or 9.2 %), and the previous demonstration from these data
that total TPN days did not differ between NEC and non-
NEC infants. However, a subsequent analysis of the model
demonstrated that this variable did not affect the model or
the outcomes. The hazard or risk function associated with
the Cox PH model is exponential in nature and can be
described as follows:
h tð Þ ¼ h0 tð Þexp βTXþ γ1PRETXþ γ2TNOFFþ γ3BM
 
Where β, γ1, γ2, and γ3 are coefficients in the model and
h0(t) is the baseline risk of TPN. In other words, this
statistical model allows for the comparison of the study
groups while incorporating other potentially important
predictors of TPN usage.
Many of the infants in the trial required multiple days
on TPN, some after having achieved full enteral feeding.
The Cox PH survival model is useful because it can take
into account the occurrence of multiple events through-
out the study period. We applied a statistical method
known as counting process theory in order to account
for those subjects with more than one time interval in
the set of intervals “at risk” for continued TPN usage [7].
Thus, this theory allows for several time-to-event inter-
vals to be considered for a single subject (See Figure 1).
The resulting series of events are considered indepen-
dent despite the fact that several outcomes originate
from the same subject. However, this is plausible because
the reason for being on TPN at different periods of time
for the same infant may vary. Our analysis thereby allows
for the calculation of the overall probability or likelihood
of needing TPN on any particular day by consolidating
the total amount of time the subject spent in this state.
However, as noted, this analysis has been simplified by
assuming that an interval on TPN is independent (in
length) of any other interval on TPN for the same indi-
vidual. Examination of the data from the current study
appears to support this assumption.
Results
Table 1 provides the parameter estimates associated with
the counting process Cox PH model. Compared toinfants on BOV diet, those on the HM100 diet had an
11 % reduction in the likelihood of requiring parenteral
nutrition (p = 0.001). Those on the HM40 diet had a
14 % reduction in this likelihood compared to the con-
trol group (p = 0.0001). There were no significant differ-
ences between the HM40 and HM100 groups.
Because the initial period of TPN, which might be un-
affected by the type of nutrition used, could have influ-
enced these results, we repeated these analyses without
including that period. For this sub-analysis, the reduc-
tions in likelihood compared to the BOV group were
24 % and 34 % for the HM100 and HM40 groups, re-
spectively (p< 0.0001). Thus, the effect of 100 % human-
milk based nutrition was not mitigated by the elimin-
ation of the initial period of TPN from the analysis.
We also evaluated only those infants that did not de-
velop NEC (n = 188) during the course of the trial. Over-
all, the human milk-based diets together showed a 7 %
reduction in the likelihood of requiring TPN (p = 0.06),
indicating that the beneficial effect of the enteral diet
persisted even in this subsample without NEC which can
prolong the need for TPN.
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safety issues seen with infants receiving any of these diets.
Discussion
The original study from which these data were drawn
was not able to show that a 100 % human milk based
diet could reduce the length of time an extremely prema-
ture infant required TPN. Indeed, the study was powered
to demonstrate a 7 day median reduction in TPN dur-
ation and found only a 2 day difference, which was not
statistically significant. However, that analysis overlooked
a key point, i.e., that all days of TPN treatment do not
carry the same clinical significance. Inevitably, most ex-
tremely premature infants begin their nutritional life re-
ceiving TPN and the ability to wean them off this and
onto enteral nutrition is not necessarily a function of the
enteral feeding itself, but may also be a function of the
infant’s clinical condition. However, once complete en-
teral nutrition is achieved, a return to TPN is likely due
to the lack of tolerance of enteral feeding. As a result, an
analysis of how long overall TPN is needed may miss the
benefits associated with an exclusively human milk-based
diet. In our current analysis, we have considered what
we believe to be a more reasonable statistical approach
that acknowledges this fact by evaluating the likelihood
of requiring TPN on any given day. This type of analysis
“rewards” an approach that would prevent a patient from
returning to TPN on at least one occasion and decreases
the importance of the duration of the initial course of
TPN, which may reflect illness severity and/or unit based
feeding practices. Our finding that the effect of 100%
human milk-based nutrition on TPN use is even more
substantial after elimination of the initial course of TPN
from the analysis further emphasizes this point. There-
fore, the current analysis provides support to the notion
that a 100 % human milk-based diet can reduce the need
for TPN by demonstrating that the likelihood of TPN
usage on a given day of life is reduced. We believe that
this is one of the key goals of a proper nutritional regi-
men. This finding persisted even after controlling for
increased incidence and severity of NEC in the control
group suggesting that this effect improves overall feeding
tolerance. This result, coupled with our previous report
of a significantly reduced risk of medical and surgical
NEC, provides further impetus for the adoption of a
100 % human milk-based diet in the NICU for infants
under 1250 grams birth weight. The finding that a more
aggressive feeding approach by introducing fortification
at a feeding volume of 40 mL/kg/day actually improved
feeding tolerance, as measured by the greater reduction
in risk of requiring TPN, is especially intriguing but
needs to be confirmed by further studies.
We note that this study has certain limitations includ-
ing the lack of information on why enteral feedings wereinterrupted and TPN restarted and the relatively small
sample size which may have affected the ability to detect
differences in actual TPN days.
Conclusions
This secondary analysis of prospectively collected data
shows that a 100 % human milk-based diet significantly
reduces the likelihood of needing nutrition via TPN for
extremely premature infants when compared to a
standard diet of human milk supplemented with cow’s
milk-based fortifier and pre-term formula when needed.
Furthermore, initiating the human milk-based fortifier
earlier may result in a further reduction in the likelihood
of TPN use in these infants.
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